Literature DB >> 20607552

Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer.

Astrid Enkelmann1, Joana Heinzelmann, Ferdinand von Eggeling, Martina Walter, Alexander Berndt, Heiko Wunderlich, Kerstin Junker.   

Abstract

PURPOSE: Tumour development and progression are strongly affected by interaction of tumour cells and tumour stroma. Different tumour models demonstrate a supportive effect of tumour-associated fibroblasts (TAF) on the tumour genesis. Aims of the present study are the isolation of TAF from primary urinary bladder tumour specimens and the proteomic and epigenetic characterisation.
METHODS: TAF were isolated from cultured urinary bladder tumour specimens. Therefore, primary tumour material was treated with EDTA followed by two separated detachment steps. Non-tumour fibroblasts were isolated from foreskin and normal bladder tissues. Proteins and total RNA were isolated from cultured fibroblasts. Protein pattern analyses were carried out by SELDI-TOF-MS. The miRNA expression profile was analysed by miRNA microarray.
RESULTS: By optimising cell culture routines, we achieved to isolate and subsequently cultivate TAF from primary tumour material of the urinary bladder. SELDI-TOF-MS measurements reveal distinct differences in the proteomic patterns of TAF and non-tumour fibroblasts. Microarray analyses indicate specific expression of several miRNAs in TAF and non-tumour fibroblasts.
CONCLUSION: In summary, we determined proteomic and epigenetic differences between non-tumour fibroblasts and TAF of urinary bladder carcinoma and identified specific protein expression patterns as well as miRNA profiles of TAF in comparison with non-tumour fibroblasts. These findings provide more insights into the complex tumour network and a good starting point for the identification of markers for the prediction of tumour development and progression based on specific TAF expression patterns.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607552     DOI: 10.1007/s00432-010-0932-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  35 in total

Review 1.  Friends or foes - bipolar effects of the tumour stroma in cancer.

Authors:  Margareta M Mueller; Norbert E Fusenig
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 2.  Microenvironmental regulation of cancer development.

Authors:  Min Hu; Kornelia Polyak
Journal:  Curr Opin Genet Dev       Date:  2008-02-20       Impact factor: 5.578

3.  Role of microRNAs in drug-resistant ovarian cancer cells.

Authors:  Antonio Sorrentino; Chang-Gong Liu; Antonio Addario; Cesare Peschle; Giovanni Scambia; Cristiano Ferlini
Journal:  Gynecol Oncol       Date:  2008-09-26       Impact factor: 5.482

4.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

5.  Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Authors:  Lars Dyrskjøt; Marie S Ostenfeld; Jesper B Bramsen; Asli N Silahtaroglu; Philippe Lamy; Ramshanker Ramanathan; Niels Fristrup; Jens L Jensen; Claus L Andersen; Karsten Zieger; Sakari Kauppinen; Benedicte P Ulhøi; Jørgen Kjems; Michael Borre; Torben F Orntoft
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

6.  Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment.

Authors:  Li Zhong; Jonathon Roybal; Raghothama Chaerkady; Wan Zhang; Kuicheon Choi; Cristina A Alvarez; Hai Tran; Chad J Creighton; Shaoyu Yan; Robert M Strieter; Akhilesh Pandey; Jonathan M Kurie
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

Review 7.  Role of microRNAs in vascular diseases, inflammation, and angiogenesis.

Authors:  Carmen Urbich; Angelika Kuehbacher; Stefanie Dimmeler
Journal:  Cardiovasc Res       Date:  2008-06-11       Impact factor: 10.787

8.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

9.  Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.

Authors:  Xiaohong Wang; Shuang Tang; Shu-Yun Le; Robert Lu; Janet S Rader; Craig Meyers; Zhi-Ming Zheng
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

10.  Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma.

Authors:  Chunyu Zhang; Li Fu; Jianhua Fu; Liang Hu; Hong Yang; Tie-Hua Rong; Yan Li; Haibo Liu; Song-Bin Fu; Yi-Xin Zeng; Xin-Yuan Guan
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

View more
  26 in total

Review 1.  Immunological basis in the pathogenesis and treatment of bladder cancer.

Authors:  David B Thompson; Larry E Siref; Michael P Feloney; Ralph J Hauke; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2014-11-13       Impact factor: 4.473

Review 2.  In vivo delivery of miRNAs for cancer therapy: challenges and strategies.

Authors:  Yunching Chen; Dong-Yu Gao; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2014-05-22       Impact factor: 15.470

3.  Fibroblast ERα promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment.

Authors:  Chiuan-Ren Yeh; Iawen Hsu; Wenbin Song; Hongchiang Chang; Hiroshi Miyamoto; Guang-Qian Xiao; Lei Li; Shuyuan Yeh
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 4.  [Epigenetic regulation of urological tumors. Importance for prognosis and metastasis].

Authors:  J Heinzelmann; B Stubendorff; V Jung; S Baumgart; S Hölters; G Unteregger; J Grimm; J Linxweiler; M Janssen; C-H Ohlmann; M Saar; S Siemer; M Stöckle; K Junker
Journal:  Urologe A       Date:  2015-06       Impact factor: 0.639

Review 5.  Stromal cells in tumor microenvironment and breast cancer.

Authors:  Yan Mao; Evan T Keller; David H Garfield; Kunwei Shen; Jianhua Wang
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

6.  Proteomic analysis of primary colon cancer-associated fibroblasts using the SELDI-ProteinChip platform.

Authors:  Zhan-Huai Wang; Ke-Feng Ding; Jie-Kai Yu; Xiao-Hui Zhai; Shu-Qin Ruan; Shan-Wei Wang; Yong-Liang Zhu; Shu Zheng; Su-Zhan Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2012-03       Impact factor: 3.066

7.  Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.

Authors:  Cheng-Ming Hsu; Pai-Mei Lin; Yu-Ming Wang; Zong-Jyun Chen; Sheng-Fung Lin; Ming-Yu Yang
Journal:  Tumour Biol       Date:  2012-07-19

Review 8.  [Tumour-stroma interactions in urothelial cancer].

Authors:  J Hatina; M Kripnerová; J Tuková; J Šrámek; P Dvořák; M Pešta; J Dobrá; V Babuška; J Racek; M Sobol; A Philimonenko; P Hozák; Z Czuba; W A Schulz; C Strell; S Grimm; S Jennek; K-H Friedrich
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

Review 9.  MicroRNAs in pancreatic cancer metabolism.

Authors:  Pankaj K Singh; Randall E Brand; Kamiya Mehla
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

Review 10.  Epithelial plasticity in urothelial carcinoma: Current advancements and future challenges.

Authors:  Minal Garg
Journal:  World J Stem Cells       Date:  2016-08-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.